This fall, Robb Akridge’s Opulus Beauty Labs will be launching stripped-down, “peak potency” skin-care formulas in the form of Opoules that users warm and blend in an Activator appliance, providing fresh, single-dose treatments. The system bears similarities to Swiss startup Réduit’s Hairpods and applicator device, as well as L’Oreal’s AI-powered Perso, slated to debut in 2021.
The global market for home-use beauty devices approached $6.5bn in 2019 and is expected to grow at a compound annual rate of 20.4% through 2030, according to Prescient & Strategic Intelligence Private Limited.
In a June report from the India-based market intelligence and consulting firm, it cites rising geriatric populations, growing prevalence...
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
